ASYS

Amtech is a small, cyclical semiconductor/industrial-machinery maker caught in a multi-year demand downturn. Revenue has fallen from a $113M peak in FY2023 to $101M (FY2024) to $79.4M (FY2025, -21.6% YoY), and profitability has collapsed alongside it: FY2025 operating income was -$28.5M (-35.9% margin), net income -$30.3M (-$2.12 diluted EPS), and ROE -56.8%. Retained earnings sit at -$75.9M. The 34.0% gross margin held up better than the bottom line, which tells you the loss is being driven by charges and de-leveraging on a shrinking top line rather than a pricing collapse — the 10-K discloses inventory write-downs jumped to ~$6.6M in FY2025 from $2.8M in FY2024, and much of the net loss is non-cash, since operating cash flow was still positive at $7.88M against just $950K of capex.

The balance sheet is the genuine strength and the reason this is not an 'avoid.' Long-term debt is a trivial $294K, cash grew 61.5% to $17.9M, current assets ($60.2M) cover current liabilities ($20.5M) nearly 3x, and liabilities/equity is only 0.74x. This company is in no financial danger and can fund itself through the trough on its own cash generation. The problem is not solvency; it's that you are being asked to pay up for it. At $18.80 the stock trades at ~5x book value ($53.4M equity / 14.4M shares ≈ $3.71/share) and 3.4x trailing sales — on revenue that is still falling and earnings that are deeply negative. That is roughly a full/peak multiple applied at a cyclical bottom.